Literature DB >> 28381512

Cell surface antibody-associated neurodegeneration: The case of anti-IgLON5 antibodies.

Russell C Dale1, Sudarshini Ramanathan2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28381512     DOI: 10.1212/WNL.0000000000003931

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  Who to Enroll in Parkinson Disease Prevention Trials? The Case for Composite Prodromal Cohorts.

Authors:  Samantha A Molsberry; Katherine C Hughes; Michael A Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2022-08-16       Impact factor: 11.800

Review 2.  Clinical Approach to Supranuclear Brainstem Saccadic Gaze Palsies.

Authors:  Alexandra Lloyd-Smith Sequeira; John-Ross Rizzo; Janet C Rucker
Journal:  Front Neurol       Date:  2017-08-23       Impact factor: 4.003

3.  Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder.

Authors:  Jasmin El Shazly; Martin Juenemann; Tibo Gerriets; Marlene Tschernatsch
Journal:  Front Neurol       Date:  2021-02-03       Impact factor: 4.003

4.  Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice.

Authors:  Sara Alvente; Gabriele Matteoli; Laura Molina-Porcel; Jon Landa; Mercedes Alba; Stefano Bastianini; Chiara Berteotti; Francesc Graus; Viviana Lo Martire; Lidia Sabater; Giovanna Zoccoli; Alessandro Silvani
Journal:  Cells       Date:  2022-03-17       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.